David Johnston, CFO, brings over thirty years of senior financial leadership experience. Currently, David Johnston, CFO, is principal of dbj Consulting LLC, providing financial and strategic advice to emerging life science companies. He was recently Chief Financial Officer for ImmunoGen, Inc., oncology-focused biotech based in Waltham, MA. During his tenure at ImmunoGen, he led several public offerings and a creative, non-dilutive royalty financing. Before ImmunoGen, David Johnston served as CFO for Aveo Oncology and Genzyme Biosurgery. He led both their initial public offerings and led several strategic initiatives, both on the buy-side and the sell-side. Mr. Johnston earned a B.S. at Washington and Lee University and an MBA at the University of Michigan. David Johnston sat on the board of directors of RAW Art Works, a nonprofit youth arts organization, and Tissue Banks International, one of the most significant eyes and tissue bank nonprofits in the United States.